August 31, 2016 8:47 PM ET


Company Overview of NovaRx Corporation

Company Overview

NovaRx Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of cell-based therapeutic vaccines for the treatment of cancer. Its products include Lucanix, a cell-based vaccine for the treatment of advanced stage non-small cell lung cancer; Glionix, a therapy for glioma (brain cancer); and a universal vaccine for patients with colon cancer, breast cancer, and prostate cancer. The company was founded in 1997 and is based in San Diego, California.

6828 Nancy Ridge Drive

Suite 100

San Diego, CA 92121

United States

Founded in 1997





Key Executives for NovaRx Corporation

Executive Chairman and Chief Executive Officer
Age: 43
Founder, Executive Vice Chairman and Chief Scientific Officer
Co-Founder and Director
Chief Financial Officer
Age: 52
Chief Operating Officer
Compensation as of Fiscal Year 2016.

NovaRx Corporation Key Developments

NovaRx Announces Management Changes

Habib Fakhrai, Ph.D., the scientific founder of NovaRx, will retain the position of Chief Scientific Officer. Todd M. Binder has joined as Activate's Chief Operating Officer. Mr. Binder is an experienced life science investor with significant operations and finance expertise, especially in the immunotherapy sector. He was an early investor in and served as acting CFO of ZetaRx.

NovaRx Announces Management Changes

Viropro Inc. has signed a non-binding letter of intent for the acquisition of NovaRx in an all-stock transaction that is expected to close by year-end. Under the terms of the letter of intent, NovaRx will have a board of directors with three members to be appointed by NovaRx, three by Viropro and one by mutual consent. Justin Murdock, a major investor in NovaRx, will be chairman of the NovaRx Board. Habib Fakhrai, the scientific founder of NovaRx and a distinguished member of the faculty of UCLA, will retain the position of chief scientific officer.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Private Placement
August 15, 2016
October 22, 2015

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NovaRx Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at